Angiotensin II receptor blockers in halting the progression of renal transplant nephropathy

2009№4

M.L. Maximov

The article presents pathogenical and clinical justification of administration of angiotensin II receptor blockers, in particular valsartan, in recipients of kidney transplant for the purpose to prevention and inhibition of progression its chronic rejection

angiotensin II receptor blockers

valsartan

chronic transplant nephropathy

Full text (in Russian)

Angiotensin II receptor blockers in halting the progression of renal transplant nephropathy

M.L. Maximov

Keywords

Similar Articles

Similar Articles

№4 / 2009
V.V. Fomin, M.M. Kurashov
From saralasin to sartans: history of the angiotensin II receptor blockade

№3 / 2010
*
Angiotension II blockers: when to use them in the beginning of antihypertensive therapy?

№5 / 2010
M.L. Maximov
Angiotensin II receptor blocker valsartan and angiotensin-converting enzyme inhibitor enalapril in hypertensive patients with renal transpalant nephropathy

№3-4 / 2016
A.G. Burmagina, A.Yu. Nikolaev
Prehypertension as a risk factor for chronic kidney disease

№1 / 2012
K.A. Giamdjan, M.L. Maksimov, V.G. Kukes
Angiotensin II receptor blocker valsartan and endothelial function in patients with chronic heart failure